RankingsPricing
  1. US-listed companies
  2. Edwards Lifesciences Corp
  3. Financials
  4. Total non-current assets

Edwards Lifesciences CorpEW

Market cap
$49.9B
P/E ratio
SummaryFinancials
Period EndTotal non-current assets (Million USD)YoY (%)
Dec 31, 20246,770+27.07%
Dec 31, 20235,328+2.52%
Dec 31, 20225,197-2.35%
Dec 31, 20215,322+28.36%
Dec 31, 20204,146+18.32%
Dec 31, 20193,504+15.39%
Dec 31, 20183,037-4.01%
Dec 31, 20173,164+39.37%
Dec 31, 20162,270+12.86%
Dec 31, 20152,011+63.57%
Dec 31, 20141,230+23.11%
Dec 31, 2013999+7.45%
Dec 31, 2012930+14.48%
Dec 31, 2011812+10.54%
Dec 31, 2010735

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)